Meal Types and Exercise Effects in Phenylketonuria
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how different meals eaten before exercise affect amino acid levels and metabolic health in adults with classic phenylketonuria (PKU)—a genetic condition affecting how your body processes protein. The research involves eating test meals, exercising, and providing blood samples to help understand the best nutritional approach for PKU patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a confirmed diagnosis of classic phenylketonuria (PKU)
- Not currently playing sports or doing regular athletic training
- Have a healthy weight (BMI between 20–28 kg/m²)
- Be willing to eat test meals and have blood drawn multiple times during the study
- Be in generally good health with no other major diseases or active infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at eating habits and disorders in people with phenylketonuria (PKU) who are treated at a specific hospital in Nancy, France. Participating involves sharing information, which may help doctors better understand eating challenges in PKU.
This study looks at how a phenylalanine-restricted diet or certain PKU medicines affect gut health in children with PKU. It also includes healthy siblings or household members as a comparison group.
This trial tests an investigational drug (AG-181) for people with PKU who have a specific genetic change (R408W mutation). It aims to check if the drug is safe and how it works in your body.
This study looks at how educational, social support, and nutrition help affect pregnancy outcomes and quality of life in women with PKU. It may help you better manage PKU-related needs before and during pregnancy.
This study tests a new medicine called sepiapterin to see if it can help control blood phenylalanine levels in people with PKU. The trial aims to find a safe and effective dose for different age groups.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
Hear when a new Phenylketonuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.